Saving A Life
Every 20 Seconds.
TB-AI is a point-of-care, smartphone-based platform for rapid, accurate, and affordable diagnosis of Tuberculosis — bringing AI to the frontline of global health.
Equitable Healthcare Through Digital Diagnostics
TB-AI is a pioneering healthtech startup that harnesses artificial intelligence to make tuberculosis diagnosis rapid, cost-effective, and accessible — even in the most resource-limited settings.
Our Mission
Equitable healthcare through digital diagnostics.
Our Vision
Accuracy, affordability, access, speed.
Our Diagnostic Services
Comprehensive AI-powered diagnostics accessible from a smartphone, anywhere in the world.
TB Diagnosis
AI-powered smear microscopy analysis for rapid, high-accuracy tuberculosis detection.
AI Diagnostic Platform
Cloud-based platform: upload slides from any smartphone, receive results in minutes.
Lab Integration
Seamless integration with existing lab infrastructure and staff training programs.
Telehealth
Remote expert consultation linking rural patients to specialist physicians nationwide.
Empowering Health Line Systems Internationally
TB-AI bridges the gap between state-of-the-art AI technology and the field clinics that need it most. Our system is designed to run on existing equipment without expensive modifications.
View Our Research97% Accuracy
Rigorous clinical testing validates our model's performance against traditional expert microscopists.
< 3 Minutes
Drastically reduces patient wait times from hours or days to minutes, facilitating immediate treatment.
Cost-Effective
Smear diagnostic costs are reduced to cents per test, over 10x cheaper than GeneXpert hardware.
Smartphone-Based
Operable on standard mid-range mobile devices with no specialized lab machinery required.
Supported & Recognized By Leading Global Organizations
What Clinical Leaders Say
Read how our platform helps speed up workflows and increase screen rates in pilot hospitals.
TB-AI in the News
Catch up on our latest press coverages and global startup features.
Diagnostic Showcases at GITEX Africa
Bloomberg highlights TB-AI's groundbreaking smear-based diagnostic algorithms presented during GITEX Africa 2024.
Read Article
State-of-the-Art Software Unveiled
CNBC Africa reports on how TB-AI makes high-speed diagnosis affordable in low-resource communities.
Read Article
Diagnosing in a Matter of Minutes
A deep dive on how our smartphone camera technique decreases microscopist bottlenecks dramatically.
Read Article